191 filings
Page 3 of 10
8-K
xhtj d85zn
15 Sep 23
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4:05pm
8-K
cu2k jats
8 Sep 23
Departure of Directors or Certain Officers
4:05pm
425
4upi0
30 Aug 23
Business combination disclosure
4:05pm
8-K
p1k bjwr3j
30 Aug 23
Serina Therapeutics and AgeX Therapeutics Enter into Merger Agreement
7:20am
8-K
39icwcb40u1eo1ls
25 Aug 23
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4:05pm
8-K
xdfkeg 98axq8ipeobo
14 Aug 23
AgeX Therapeutics Reports Second Quarter 2023 Financial Results
4:25pm
8-K
iilhzy15uov mt
4 Aug 23
Entry into a Material Definitive Agreement
4:05pm
8-K
augu7g7s2
24 Jul 23
AgeX Therapeutics Closes $36,000,000 Debt Exchange for Preferred Stock
6:37pm
8-K
a0teoh50pux7k266
21 Jul 23
AgeX Therapeutics Announces $36,000,000 Debt Exchange for Preferred Stock
5:29pm
8-K
37nc4q5p8
7 Jul 23
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4:05pm
8-K
wy9a2ueau 7qggt0hd
8 Jun 23
Entry into a Material Definitive Agreement
4:05pm
8-K
f22ohoun2a3grp8i
23 May 23
Agex Therapeutics Announces Appeal of Nyse American Determination
4:15pm
8-K
t5vql
12 May 23
AgeX Therapeutics Reports First Quarter 2023 Financial Results
4:25pm
8-K
uf7 otg2h3lwdmu428
26 Apr 23
Agex Therapeutics Receives Stock Exchange Deficiency Letter
4:15pm
8-K
dji5lamc
6 Apr 23
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4:05pm
8-K
n0xtjewvbxjiv cl
31 Mar 23
AgeX Therapeutics Reports Fourth Quarter and Annual 2022 Financial Results
4:25pm